United States & Bayer
12 shared events · Importance 4 · Last updated Jul 02, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
United States: The ruling affects U.S. tort law and pesticide regulation; the Trump administration supported Bayer, while some lawmakers criticized the decision.
Bayer: Bayer is the primary beneficiary; the ruling shields it from thousands of failure-to-warn lawsuits, reducing litigation risk and boosting investor confidence. Shares rose ~18%.
Jun 25, 2026 · 133 articles
Business
United States: The consolidation specifically targets the U.S. glyphosate market, with Ruveon LLC based in St. Louis, Missouri, and focused on supplying the U.S. agriculture industry.
Bayer: Bayer Group is consolidating its U.S. glyphosate business into Ruveon LLC to optimize operations and enhance focus on innovation and profitability within its Crop Science division.
Jul 01, 2026 · 6 articles
Business
United States: The United States is Bayer's largest Consumer Health market, and a new President for this region was appointed as part of the leadership changes.
Bayer: Bayer announced leadership changes within its Consumer Health division to accelerate growth and strengthen commercial execution, aiming to enhance its 'Road to Billions' strategy.
Jun 08, 2026 · 7 articles
Business
United States: Major market and home to several key players.
Bayer: Mentioned as player; limited direct impact.
Jul 08, 2026 · 6 articles
International
United States: US enforces naval blockade and claims control; seeks to reopen strait but faces domestic pressure over high fuel prices.
Bayer: Bayer fell, minor impact.
Jul 28, 2026 · 318 articles
Tech
United States: The United States>>> is a key market for prostate cancer treatment, with a significant number of high-risk patients who could benefit from Apalutamide>>>.
Bayer: Bayer>>> is mentioned as a competitor with its ARPI drug Nubeqa, indicating potential market competition with Johnson & Johnson>>>'s Apalutamide>>>.
May 31, 2026 · 6 articles
Tech
Bayer: Bayer's subsidiary, MiNK Therapeutics, is exploring approaches related to regulatory T cells, showing the company's involvement in this emerging field.
Oct 06, 2025 · 6 articles
Business
Bayer: Bayer has agreed to a proposed $7.25 billion settlement to resolve thousands of lawsuits alleging its Roundup weedkiller causes cancer, aiming to reduce litigation uncertainty and financial strain. This settlement is crucial for Bayer's financial survival and ability to continue selling Roundup in agricultural markets.
Feb 17, 2026 · 10 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how United States and Bayer interact across events, view sentiment trends, and discover connected entities.
Open Dashboard